Clinical trial
Evaluation of a New Customized Corneal Treatment for Laser Refractive Vision Correction Using the TENEO™ 317 Model 2
NCT06997003 is registered in ClinicalTrials.gov with Bausch & Lomb GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of a New Customized Corneal Treatment for Laser Refractive Vision Correction Using the TENEO™ 317 Model 2
- Lead sponsor
- Bausch & Lomb GmbH
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 16, 2025
- Completion date
- September 30, 2026
- Enrollment
- 81 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hyperopia and myopia